There is a greater risk of hormone receptor–positive breast cancer if a patient is obese. Researchers from the University of Louisville have discovered a possible new link between obesity and a greater risk for developing breast cancer: adipose fatty acid binding protein.
There is a greater risk of hormone receptor—positive breast cancer if a patient is obese. Researchers from the University of Louisville James Graham Brown Cancer Center have discovered a possible new link between obesity and a greater risk for developing breast cancer: adipose fatty acid binding protein, or FABP4. Their results published online last week in Trends in Molecular Medicine demonstrate a likely connection between accumulation of fat tissue, the release of greater amounts of circulating FABP4, and breast cancer tumor growth.
“In our research, we found the fatty acid binding protein family, especially one member, FABP4, plays a very critical role in the association of obesity and cancer, most specifically breast cancer. We theorize that FABP4 is responsible for the underlying molecular mechanism which promotes obesity-associated breast cancer development,” stated Bing Li, PhD, associate professor in the department of microbiology and immunology and James Graham Brown Cancer Center at the University of Louisville, and one of the study’s authors.
He proposes 2 mechanisms of action for why the connection exists:
“When we get obese, this protein is secreted out much more into the circulatory system,” Li said. “Normally these molecules are inside the cells, but when people are obese, the molecules are outside.”
The FABP4 family of proteins evolved as a way for water-soluble dietary long-chain fatty acids to be absorbed and used by our tissues. Essentially, they are the logistic engineers for where fatty acids go and how they are used. However, individuals who are considered obese have greater amounts of adipose tissue, which is an indicator of higher levels of FABP4, and that increases their body mass index and affects hormone production.
Additional evidence shows that FABP4 “is able to bind [free fatty acids] and provide energy for rapid ovarian tumor growth and metastasis,” as well as blocks the activity of tumor-suppressor genes in myeloid-derived leukemia cells. Therefore, the study results indicate, hindering FABP4 could hinder tumor growth.
“Targeting FABP4 with either small molecular inhibitors or specific antibodies has been shown to be feasible in other disease settings. Considering the persistent risk of breast cancer recurrence after current therapeutic strategies,” the study authors noted, “inhibition of FABP4 activity might offer a novel strategy for the treatment of obesity-associated breast cancer.”
Reference
Zeng J, Sauter ER, Li B. FABP4: a new player in obesity-associated breast cancer [published online April 7, 2020]. Trends Mol Med. doi: 10.1016/j.molmed.2020.03.004
Metabolic Syndrome, Obesity Contribute to Breast Cancer Mortality in Postmenopausal Women
May 13th 2024A large study finds that obesity and metabolic syndrome raise breast cancer mortality risk, but through different mechanisms. Metabolic syndrome is linked to a specific type of breast cancer, whereas obesity increases risk across all breast cancer subtypes.
Read More
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Social Equity, Strong Health Care Systems Can Improve Advanced Breast Cancer Outcomes Globally
May 6th 2024Disparities in health care systems around the world limit access to effective treatments for advanced breast cancer, especially for people in low- and middle-income countries and marginalized communities. Stronger health systems and social education efforts are necessary to improve outcomes for all patients.
Read More
The Disproportionate Impact of the Pandemic on Health Care Disparities and Cancer
February 22nd 2022On this episode of Managed Care Cast, we discuss how already wide health care inequities in cancer are becoming much worse because of the COVID-19 pandemic, with guest Monica Soni, MD, associate chief medical officer at New Century Health.
Listen
USPSTF Lowers Age for Biennial Mammograms to 40, Citing Early Detection Benefit
April 30th 2024The USPSTF lowered the recommended starting age for mammograms from 50 to 40 years, citing moderate benefits for early detection in this age group. Disparities persist, especially for Black women, highlighting the need for improved access to health care and social support.
Read More
Metabolic Syndrome, Obesity Contribute to Breast Cancer Mortality in Postmenopausal Women
May 13th 2024A large study finds that obesity and metabolic syndrome raise breast cancer mortality risk, but through different mechanisms. Metabolic syndrome is linked to a specific type of breast cancer, whereas obesity increases risk across all breast cancer subtypes.
Read More
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Social Equity, Strong Health Care Systems Can Improve Advanced Breast Cancer Outcomes Globally
May 6th 2024Disparities in health care systems around the world limit access to effective treatments for advanced breast cancer, especially for people in low- and middle-income countries and marginalized communities. Stronger health systems and social education efforts are necessary to improve outcomes for all patients.
Read More
The Disproportionate Impact of the Pandemic on Health Care Disparities and Cancer
February 22nd 2022On this episode of Managed Care Cast, we discuss how already wide health care inequities in cancer are becoming much worse because of the COVID-19 pandemic, with guest Monica Soni, MD, associate chief medical officer at New Century Health.
Listen
USPSTF Lowers Age for Biennial Mammograms to 40, Citing Early Detection Benefit
April 30th 2024The USPSTF lowered the recommended starting age for mammograms from 50 to 40 years, citing moderate benefits for early detection in this age group. Disparities persist, especially for Black women, highlighting the need for improved access to health care and social support.
Read More
2 Commerce Drive
Cranbury, NJ 08512